CT
ACAD icon

Colonial Trust’s Acadia Pharmaceuticals ACAD Stock Holding History

Colonial Trust’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.3K Hold
131
– – ﹤0.01% 958
2026
Q1 		$2.76K Hold
131
– – ﹤0.01% 971
2025
Q4 		$3.5K Hold
131
– – ﹤0.01% 922
2025
Q3 		$3.17K Sell
131
-16
-11% -$378 ﹤0.01% 930
2025
Q2 		$3.25K Hold
147
– – ﹤0.01% 909
2025
Q1 		$2.51K Buy
+147
New +$2.67K ﹤0.01% 944

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Colonial Trust's ACAD Position: Q2 2026 in Review

Colonial Trust held its Acadia Pharmaceuticals (ACAD) position steady in Q2 2026 at 131 shares worth $3.3K. The position accounts for ﹤0.01% of the portfolio, ranked #958.

Colonial Trust first reported a position in ACAD in Q1 2025 and has held it in 6 quarters since. The position peaked at $3.5K in Q4 2025. 354 funds tracked by Wall St. Rank hold ACAD as of Q2 2026.

  • Colonial Trust held 131 shares of Acadia Pharmaceuticals worth $3.3K as of Q2 2026.
  • Colonial Trust left its Acadia Pharmaceuticals share count unchanged in Q2 2026.
  • Acadia Pharmaceuticals made up ﹤0.01% of Colonial Trust's portfolio in Q2 2026, its #958 holding.
  • Colonial Trust first reported a position in Acadia Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • Colonial Trust's Acadia Pharmaceuticals position peaked at $3.5K in Q4 2025.
  • 354 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2026.

Based on Colonial Trust's 13F filing for Q2 2026, filed 11 Aug 2026.